M-GNN: A Graph Neural Network Framework for Lung Cancer Detection Using Metabolomics and Heterogeneous Graph Modeling
Preprint
- 25 March 2025
- preprint
- Published by MDPI AG in Preprints.org
Abstract
Lung cancer remains the leading cause of cancer-related mortality worldwide, with early detection critical for improving survival rates, yet conventional methods like CT scans often yield high false-positive rates. This study introduces M-GNN, a Graph Neural Network framework leveraging GraphSAGE, to enhance early lung cancer detection through metabolomics. We constructed a heterogeneous graph integrating metabolomics data from 800 plasma samples (586 cases, 214 controls) with demographic features and Human Metabolome Database annotations, employing GraphSAGE and GAT layers for inductive learning on 107 metabolites, pathways, and diseases. M-GNN achieved a test accuracy of 93% and an ROC-AUC of 0.96, with rapid convergence within 400 epochs and robust performance across ten random seeds; key predictors included cigarette pack years, choline, and taurine, reflecting smoking and metabolic dysregulation. This framework offers a scalable, interpretable tool for precision oncology, surpassing benchmarks by capturing complex biological interactions, though limitations like synthetic data biases and computational demands suggest future validation with real-world cohorts and optimization. M-GNN advances lung cancer screening, promising improved survival through early detection and personalized strategies.Keywords
All Related Versions
This publication has 27 references indexed in Scilit:
- Serum taurine affects lung cancer progression by regulating tumor immune escape mediated by the immune microenvironmentJournal of Advanced Research, 2024
- An end-to-end deep learning method for mass spectrometry data analysis to reveal disease-specific metabolic profilesNature Communications, 2024
- DADFN: dynamic adaptive deep fusion network based on imaging genomics for prediction recurrence of lung cancerPhysics in Medicine & Biology, 2023
- High-resolution metabolomic biomarkers for lung cancer diagnosis and prognosisScientific Reports, 2021
- An end-to-end heterogeneous graph representation learning-based framework for drug–target interaction predictionBriefings in Bioinformatics, 2021
- Early lung cancer diagnostic biomarker discovery by machine learning methodsTranslational Oncology, 2020
- Metabolomic study of serum, urine and bronchoalveolar lavage fluid based on gas chromatography mass spectrometry to delve into the pathology of lung cancerJournal of Pharmaceutical and Biomedical Analysis, 2019
- A review of metabolism-associated biomarkers in lung cancer diagnosis and treatmentMetabolomics, 2018
- Choline metabolism in malignant transformationNature Reviews Cancer, 2011
- HMDB: the Human Metabolome DatabaseNucleic Acids Research, 2007